Off-label use of a common antibiotic to treat muscular dystrophy
Researchers are optimistic about the efficacy and safety of the antibiotic erythromycin in treating myotonic dystrophy type 1, a form of muscular dystrophy. …
Researchers are optimistic about the efficacy and safety of the antibiotic erythromycin in treating myotonic dystrophy type 1, a form of muscular dystrophy. …
New research indicates that more screen time at age two is associated with poorer communication and daily living skills at age four, but outdoor play can reduce some negative effects of screen time. …
Routine dietary supplementation with tricaprin results in regression of coronary atherosclerosis and resolution of symptoms in a subset of patients. …
Postmortem analysis of a patient with clinically typical Parkinson’s disease revealed an unexpected accumulation of TDP-43 protein in the brain, indicating an alternative disease mechanism. …
Mesenchymal stem cell therapy suppresses the onset of type 1 diabetes induced by cancer immunotherapy. …
Researchers develop a novel vaccine that removes senescent immune cells from the body to improve obesity-induced metabolic disorders. …
Researchers have identified specific changes in the gut microbiome that are linked to colorectal cancer. …
Researchers developed a novel gene therapy approach that blocks the accumulation of α-synuclein in the brain, preventing the development of Parkinson’s disease. …
Inflammatory bowel disease (IBD), such as Crohn disease and ulcerative colitis, are chronic inflammatory diseases of unknown cause, and the number of IBD patients is on the rise. …
Scientists have discovered that elimination of adipose tissue oxidative stress (Fat ROS) decreases lipid accumulation in the liver, clinically improving insulin resistance and inducing metabolically healthy obesity. …
End of content
End of content